EGFR tyrosine kinase inhibitor combined with concurrent or sequential chemotherapy for patients with advanced lung cancer and gradual progression after first-line EGFR-TKI therapy: A randomized controlled study
Chang, Qing, Xu, Jianlin, Qiang, Huiping, Teng, Jiajun, Qian, Jialin, Lv, Minfang, Zhang, Yanwei, Lou, Yuqing, Zhao, Yizhuo, Zhong, Runbo, Han, Baohui, Chu, TianqingJournal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2020.06.005
Date:
July, 2020
File:
PDF, 2.05 MB
2020
File converter
More search results
More benefits 
